Reproductive Hormone Market - Hormonal Regulation of the Reproductive System | Detailed Study by Coherent Market Insights with Upcoming Trends

Global Reproductive Hormone Market Analysis

Overview

Various medical fertility disorders are treated using artificially developed reproductive hormones. Divigel, Cenestin, Femtrace, Ogen, and Menest are some of the brands available on the market. Fertility and attractiveness are heavily influenced by reproductive hormones. Progesterone and Estrogen are the essential hormones in females that aid in the management of sex characteristics and play a role in the menstrual cycle, reproduction, and pregnancy. Likewise, testosterone is an essential hormone in males that aids in the development of sperm in the testes.

Get Sample PDF Including COVID-19 Impact Analysis: https://www.coherentmarketinsights.com/insight/request-sample/3185

The synthetic development of such hormones can be accomplished in two ways: source analogues and recombinant hormones. The source of hormone is readily accessible in source analogues; for example, urinary hCG is a LH like analogue. Pregnant women's urine is used to make the LH preparation. As a result of variations in bioactivity, such hormones can vary from batch to batch. Recombinant hormones are also made from transfected Chinese hamster ovary cells and distilled using the immunoaffinity chromatography method.

Drivers

Due to rising drug approvals for reproductive hormones, the scope of the global reproductive hormone market is projected to grow over the forecast period. TherapeuticsMD Inc., obtained FDA clearance in 2018 for its BIJUVA Capsules, which are used to relieve menopause-related vasomotor symptoms.

Moreover, the rising number of women experiencing infertility is expected to propel growth of the global reproductive hormone market during the forecast period. According to the World Health Organization, there were 48.5 million infertile couples worldwide in 2010. In addition, according to a study commissioned by the Centers for Disease Control and Prevention, 1 in 8 couples in the U.S. had difficulty sustaining pregnancy between 2006 and 2010. As a result, the global problem of infertility is projected to fuel growth of the global reproductive hormone market.

Tailored Information as per niche requirement:

LIMITED TIME OFFER - Hurry Up!

Exclusive offer!!! Purchase the report at a discounted rate!!!

Get Discount For Buyers UPTO 30% OFF On Any Research Report

Buy Now with Discount for Premium Report 2021: https://www.coherentmarketinsights.com/promo/buynow/3185

Restraints

Increased prescription recalls are a big stumbling block to the reproductive hormone market's expansion. Owing to a violation of common good production standards identified by a US FDA inspection, Medisca Inc. voluntarily released recalls for its hormone products ESTRIOL, USP Bulk, ESTRADIOL, Hemihydrate (USP Bulk), Micronized (USP) Bulk, and ESTRONE in 2017.

Regional Analysis

Due to increased prescription approval and releases of reproductive hormones in the U.S., North America is predicted to dominate the global reproductive hormone market in the forecasted years. AbbVie Inc.'s ORILISSA (elagolix) drug obtained FDA approval in the U.S. for the treatment of moderate-to-severe pain associated with endometriosis. Likewise, Ferring Pharmaceuticals added Ganirelix Acetate Injection to its product line in January 2019, acquiring the U.S. commercialization rights from Sun Pharmaceutical Industries Ltd. Ferring Pharmaceuticals increased its reproductive medicine portfolio offerings in the U.S. of this policy.

Over the forecast period, Asia Pacific is predicted to be the fastest growing region in the global reproductive hormone market. According to the Economist Intelligence Unit Limited's 2019 survey, Southeast Asia's fertility rate dropped from 5.5 to 2.4 between 1970 and 2015. It is expected to drop to 2.1 by 2030, owing to lower fertility rates in a few nations, including Malaysia, Vietnam, and Thailand, which were 1.90, 2.04, and 1.58, respectively, in 2017.

Special Requirements?

We value your investment and offer customization as per your requirements.

Share your precise requirements @ https://www.coherentmarketinsights.com/insight/request-customization/3185

Competitive landscape

Major companies contributing in the global reproductive hormone market are Allergan plc., Novo Nordisk A/S, AbbVie Inc., Endo Pharmaceuticals Inc., and Pfizer Inc.

Table of Content

Global Reproductive Hormone Market Research Report

Section 1: Global Reproductive Hormone Industry Overview

Section 2:  Global Economic Impact on Reproductive Hormone Industry

Section 3:  Global Market Competition by Industry Producers

Section 4:  Global Productions, Revenue (Value), according to Regions

Section 5:  Global Supplies (Production), Consumption, Export, Import, geographically

Section 6:  Global Productions, Revenue (Value), Price Trend, Product Type

Section 7:  Global Market Analysis, on the basis of Application

Section 8:  Reproductive Hormone Market Pricing Analysis

Section 9:  Market Chain, Sourcing Strategy and Downstream Buyers

Section 10:  Strategies and key policies by Distributors/Suppliers/Traders

Section 11:  Key Marketing Strategy Analysis, by Market Vendors

Section 12:  Market Effect Factors Analysis

Section 13:  Global Reproductive Hormone Market Forecast

Have a Look at Related Research Insights:

PORCINE VACCINES MARKET ANALYSIS

GENERIC DRUGS MARKET ANALYSIS

SWINE RESPIRATORY DISEASE TREATMENT MARKET ANALYSIS

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837